• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管主动脉瓣植入术相关围手术期脑梗死的部位分布。

Topographical distribution of perioperative cerebral infarction associated with transcatheter aortic valve implantation.

机构信息

The Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia; The Heart & Lung Institute, Metro North Hospital and Health Service, Brisbane, Australia; The University of Queensland, Brisbane, Australia.

The University of Queensland, Brisbane, Australia; Department of Medical Imaging, The Prince Charles Hospital, Brisbane, Australia.

出版信息

Am Heart J. 2018 Mar;197:113-123. doi: 10.1016/j.ahj.2017.12.008. Epub 2017 Dec 8.

DOI:10.1016/j.ahj.2017.12.008
PMID:29447771
Abstract

BACKGROUND

Transcatheter aortic valve implantation (TAVI) is associated with a high incidence of cerebrovascular injury. As these injuries are thought to be primarily embolic, neuroprotection strategies have focused on embolic protection devices. However, the topographical distribution of cerebral emboli and how this impacts on the effectiveness of these devices have not been thoroughly assessed. Here, we evaluated the anatomical characteristics of magnetic resonance imaging (MRI)-defined cerebral ischemic lesions occurring secondary to TAVI to enhance our understanding of the distribution of cardioembolic phenomena.

METHODS

Forty patients undergoing transfemoral TAVI with an Edwards SAPIEN-XT valve under general anesthesia were enrolled prospectively in this observational study. Participants underwent brain MRI preprocedure, and 3 ± 1 days and 6 ± 1 months postprocedure.

RESULTS

Mean ± SD participant age was 82 ± 7 years. Patients had an intermediate to high surgical risk, with a mean Society of Thoracic Surgeons score of 6.3 ± 3.5 and EuroSCORE of 18.1 ± 10.6. Post-TAVI, there were no clinically apparent cerebrovascular events, but MRI assessments identified 83 new lesions across 19 of 31 (61%) participants, with a median ± interquartile range number and volume of 1 ± 2.8 lesions and 20 ± 190 μL per patient. By volume, 80% of the infarcts were cortical, 90% in the posterior circulation and 81% in the right hemisphere.

CONCLUSIONS

The distribution of lesions that we detected suggests that cortical gray matter, the posterior circulation, and the right hemisphere are all particularly vulnerable to perioperative cerebrovascular injury. This finding has implications for the use of intraoperative cerebral embolic protection devices, particularly those that leave the left subclavian and, therefore, left vertebral artery unprotected.

摘要

背景

经导管主动脉瓣植入术(TAVI)与脑血管损伤的发生率较高有关。由于这些损伤被认为主要是栓塞性的,因此神经保护策略集中在栓塞保护装置上。然而,尚未彻底评估脑栓塞的地形分布以及这如何影响这些装置的有效性。在这里,我们评估了继发于 TAVI 的磁共振成像(MRI)定义的脑缺血性病变的解剖特征,以增强我们对心源性栓塞现象分布的理解。

方法

前瞻性地纳入了 40 名接受全身麻醉下经股动脉 TAVI 治疗并植入 Edwards SAPIEN-XT 瓣膜的患者。所有患者在术前、术后 3 ± 1 天和 6 ± 1 个月进行了脑部 MRI 检查。

结果

患者的平均年龄 ± 标准差为 82 ± 7 岁。患者的手术风险处于中高危水平,平均胸外科医师协会评分(STS)为 6.3 ± 3.5,欧洲心脏手术风险评分(EuroSCORE)为 18.1 ± 10.6。TAVI 后,无明显的脑血管事件,但 MRI 评估发现 31 名患者中的 19 名(61%)有 83 个新病变,中位数 ± 四分位距的病变数量和体积分别为 1 ± 2.8 个和 20 ± 190 μL/患者。就体积而言,80%的梗死灶位于皮质,90%位于后循环,81%位于右侧半球。

结论

我们检测到的病变分布表明,皮质灰质、后循环和右侧半球都特别容易受到围手术期脑血管损伤的影响。这一发现对术中脑栓塞保护装置的使用具有重要意义,特别是那些留下左侧锁骨下动脉和因此左侧椎动脉未受保护的装置。

相似文献

1
Topographical distribution of perioperative cerebral infarction associated with transcatheter aortic valve implantation.经导管主动脉瓣植入术相关围手术期脑梗死的部位分布。
Am Heart J. 2018 Mar;197:113-123. doi: 10.1016/j.ahj.2017.12.008. Epub 2017 Dec 8.
2
Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial.经导管主动脉瓣植入术治疗重度主动脉瓣狭窄患者中脑保护装置对脑损伤的影响:CLEAN-TAVI 随机临床试验。
JAMA. 2016 Aug 9;316(6):592-601. doi: 10.1001/jama.2016.10302.
3
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis.经导管主动脉瓣植入术后的无症状性脑损伤及栓子保护装置的预防作用:一项系统评价和荟萃分析。
Int J Cardiol. 2016 Oct 15;221:97-106. doi: 10.1016/j.ijcard.2016.06.143. Epub 2016 Jun 27.
4
Neurological Injury in Intermediate-Risk Transcatheter Aortic Valve Implantation.中度风险经导管主动脉瓣植入术中的神经损伤
J Am Heart Assoc. 2016 Nov 15;5(11):e004203. doi: 10.1161/JAHA.116.004203.
5
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.首例人体研究评估 Emblok 栓塞保护系统在经导管主动脉瓣置换术中的应用。
JACC Cardiovasc Interv. 2020 Apr 13;13(7):860-868. doi: 10.1016/j.jcin.2019.11.017.
6
Neurologic Complications of Unprotected Transcatheter Aortic Valve Implantation (from the Neuro-TAVI Trial).无保护经导管主动脉瓣植入术的神经系统并发症(来自Neuro-TAVI试验)
Am J Cardiol. 2016 Nov 15;118(10):1519-1526. doi: 10.1016/j.amjcard.2016.08.013. Epub 2016 Aug 23.
7
Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.经导管主动脉瓣置换术中基于滤器的全脑栓塞保护
Catheter Cardiovasc Interv. 2018 Mar 1;91(4):790-797. doi: 10.1002/ccd.27323. Epub 2017 Sep 12.
8
Cerebral protection devices during transcatheter aortic valve implantation.经导管主动脉瓣植入术中的脑保护装置
Trends Cardiovasc Med. 2018 Aug;28(6):412-418. doi: 10.1016/j.tcm.2018.01.007. Epub 2018 Feb 2.
9
TriGuard HDH embolic deflection device for cerebral protection during transcatheter aortic valve replacement.用于经导管主动脉瓣置换术中脑保护的TriGuard HDH栓子偏转装置。
Catheter Cardiovasc Interv. 2017 Feb 15;89(3):470-477. doi: 10.1002/ccd.26566. Epub 2016 Apr 28.
10
Cerebral embolic protection systems for transcatheter aortic valve replacement.用于经导管主动脉瓣置换术的脑栓塞保护系统。
J Interv Cardiol. 2018 Dec;31(6):891-898. doi: 10.1111/joic.12573. Epub 2018 Nov 22.

引用本文的文献

1
Neuroprotection Devices in Cardiac Catheterization Laboratories: Does It Sufficiently Protect Our Patients?心脏导管实验室中的神经保护装置:它是否能充分保护我们的患者?
Medicina (Kaunas). 2025 Feb 10;61(2):305. doi: 10.3390/medicina61020305.
2
Cerebral embolic protection during transcatheter heart interventions.经导管心脏介入术中的脑栓塞保护。
EuroIntervention. 2023 Sep 18;19(7):549-570. doi: 10.4244/EIJ-D-23-00166.
3
Stroke prevention during and after transcatheter aortic valve implantation: From cerebral protection devices to antithrombotic management.
经导管主动脉瓣植入术中及术后的卒中预防:从脑保护装置到抗栓管理。
Front Cardiovasc Med. 2022 Oct 17;9:958732. doi: 10.3389/fcvm.2022.958732. eCollection 2022.
4
Anemia and risk of periprocedural cerebral injury detected by diffusion-weighted magnetic resonance imaging in patients undergoing transcatheter aortic valve replacement.经导管主动脉瓣置换术患者中,通过磁共振扩散加权成像检测贫血与围手术期脑损伤风险的关系
World J Emerg Med. 2022;13(1):32-39. doi: 10.5847/wjem.j.1920-8642.2022.025.
5
"Tailor-made" Total Cerebral Protection during Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术中的“定制化”全脑保护。
Neurol Med Chir (Tokyo). 2021 Dec 15;61(12):741-749. doi: 10.2176/nmc.oa.2021-0005. Epub 2021 Oct 7.
6
Reduction of Cerebral Emboli: In vitro Study with a Novel Cerebral Embolic Protection Device.减少脑栓塞:使用新型脑栓塞保护装置的体外研究。
Med Devices (Auckl). 2020 Mar 12;13:67-73. doi: 10.2147/MDER.S234961. eCollection 2020.
7
Cerebral Embolic Protection in TAVI: Friend or Foe.经导管主动脉瓣植入术中的脑栓塞保护:是友还是敌?
Interv Cardiol. 2019 Feb;14(1):22-25. doi: 10.15420/icr.2018.32.2.